Anne Keating, the executive director and worldwide development project leader for oncology at Astellas, has earned a Luminary honor from the Health Businesswomen’s Association.
Keating will receive the award at the New York Hilton Midtown as part of the 27th Woman of the Year celebratory event. Approximately 2,500 leaders in the health industry were invited to attend.
The purpose of the award is to show the impact and advancement of women involved in the business of health care industry. The award encourages women to continue being leaders and innovators in the medical industry.
Women who receive the Luminary award have over 20 years of experience in their professional industries. They must be active mentors, role models for their company -- encouraging others and showing transformational leadership skills.
Keating has over 20 years of experience in drug development projects for the pharmaceutical industry. She started at Astellas as the company’s director of clinical operations. She has also been the senior director of project management for the medical and development department.
In addition, she actively volunteers at the University of Illinois College of Pharmacy. She encourages pharmacy students to pursue careers in developing drugs to help people around the world.
"Anne is always inspiring, influencing and guiding women to achieve their very best and advance their careers in healthcare," Claire Thom, therapeutic area head for Oncology at Astellas, said. "Her exemplary leadership and commitment to others represents the passion and the sense of purpose that we all share at Astellas."
